{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:20:38Z","timestamp":1771690838223,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>While immunotherapy tends to be ineffective against pancreatic ductal adenocarcinoma (PDAC), this cancer type often elicits B-cell immunity. However, the exact antigens responsible for these spontaneous immune responses are still unclear. This study used a unique high-dimensional ELISA to analyze IgG responses to 93 post-translational modifications and other chemical determinants in PDAC patients at the time of diagnosis and before therapy. Results identified 13 specific targets of serum IgG that distinguished PDAC patients from healthy donors. Phosphorylated-serine, -threonine, and -tyrosine emerged as the primary targets, with most patients showing high-titer IgG, predominantly of the IgG1 and IgG3 subclasses. Moreover, serum reactivity to these phosphorylated residues was higher in patients with metastatic disease, suggesting a relation between B cell immunity and tumor burden. Lastly, immunofluorescence staining and phosphoproteomic analysis provided evidence of the accumulation of phosphorylated amino acids in PDAC cells and identified a series of consensus abnormal phosphosites. Overall, our findings reveal for the first time the development of robust antibody responses targeting phosphorylated residues in PDAC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1501943","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:31:51Z","timestamp":1743147111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Talita","family":"Aguiar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Mashiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesava","family":"Asam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poulomi","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Dietzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca G. Z.","family":"Schahadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattea","family":"Ausmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe Ran Susan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Aouizerat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine M.","family":"Genkinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Remotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"B1","volume-title":"Cancer facts and Figures 2024","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2011.021","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101388","DOI":"10.1016\/j.smim.2020.101388","article-title":"Development of autoantibody signatures for common cancers","volume":"47","author":"Kobayashi","year":"2020","journal-title":"Semin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80053-2","article-title":"Serological identification of human tumor antigens","volume":"9","author":"Sahin","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host","volume":"92","author":"Sahin","year":"1995","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0248","article-title":"An autoimmune response signature associated with the development of triple-negative breast cancer reflects disease pathogenesis","volume":"75","author":"Katayama","year":"2015","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2560","article-title":"Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women","volume":"73","author":"Ladd","year":"2013","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051931","article-title":"Autoantibody signatures in prostate cancer","volume":"353","author":"Wang","year":"2005","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1536","article-title":"Whole genome-derived tiled peptide arrays detect prediagnostic autoantibody signatures in non-small-cell lung cancer","volume":"79","author":"Yan","year":"2019","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/acs.jproteome.6b00559","article-title":"Serum protein markers for the early detection of lung cancer: A focus on autoantibodies","volume":"16","author":"Broodman","year":"2017","journal-title":"J Proteome Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.trecan.2017.02.003","article-title":"Autoantibodies: opportunities for early cancer detection","volume":"3","author":"Macdonald","year":"2017","journal-title":"Trends Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12935-023-03107-1","article-title":"A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1330419","article-title":"Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma","volume":"14","author":"Maimela","year":"2024","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1021\/pr070281a","article-title":"Autoantibody signature in human ductal pancreatic adenocarcinoma","volume":"6","author":"Tomaino","year":"2007","journal-title":"J Proteome Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v152.5","article-title":"Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma","volume":"152","author":"Zhuang","year":"2023","journal-title":"Int J Cancer J Int du Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35702\/onc.10012","article-title":"Post-translational modifications (PTMs), from a cancer perspective: an overview","volume":"2","author":"Sharma","year":"2019","journal-title":"Oncogen"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cas.v112.1","article-title":"New horizons of DNA adductome for exploring environmental causes of cancer","author":"Totsuka","year":"2020","journal-title":"Cancer Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jprot.2016.10.003","article-title":"Lysine acetylation and cancer: A proteomics perspective","volume":"150","author":"Gil","year":"2017","journal-title":"J Proteomics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1304639","article-title":"Ubiquitin signaling in pancreatic ductal adenocarcinoma","volume":"10","author":"Lv","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01119-6","article-title":"The SUMO pathway in pancreatic cancer: insights and inhibition","volume":"124","author":"Schneeweis","year":"2021","journal-title":"Br J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade8872","article-title":"Broad responses to chemical adducts shape the natural antibody repertoire in early infancy","volume":"9","author":"Mashiko","year":"2023","journal-title":"Sci Adv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00047-8","article-title":"Autoimmunity seen through the SEREX-scope","volume":"2","author":"Krebs","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/pr100213b","article-title":"Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer","volume":"10","author":"Tomaino","year":"2011","journal-title":"J Proteome Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add8469","article-title":"Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer","volume":"15","author":"Lastwika","year":"2023","journal-title":"Sci Trans Med"},{"key":"B26","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Clinical Proteomic Tumor Analysis C. Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.647387","article-title":"LMO7 as an unrecognized factor promoting pancreatic cancer progression and metastasis","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12935-022-02467-4","article-title":"Pan-cancer analysis identifies LMNB1 as a target to redress Th1\/Th2 imbalance and enhance PARP inhibitor response in human cancers","volume":"22","author":"Qin","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235953","article-title":"Progesterone receptor membrane component (PGRMC)1 and PGRMC2 and their roles in ovarian and endometrial cancer","volume":"13","author":"Peluso","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac078","article-title":"Pleiotropic actions of PGRMC proteins in cancer","volume":"163","author":"Pru","year":"2022","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111490","article-title":"Targeting BET proteins decreases hyaluronidase-1 in pancreatic cancer","volume":"12","author":"Kumar","year":"2023","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"113554","DOI":"10.1016\/j.celrep.2023.113554","article-title":"3D matrix adhesion feedback controls nuclear force coupling to drive invasive cell migration","volume":"42","author":"Newman","year":"2023","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13578-022-00821-7","article-title":"The phosphorylation to acetylation\/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA\/histone-modifying enzymes","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-022-01271-x","article-title":"3D chromatin architecture and transcription regulation in cancer","volume":"15","author":"Deng","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730746","article-title":"Tumor-infiltrating B- and T-cell repertoire in pancreatic cancer associated with host and tumor features","volume":"12","author":"Pineda","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i11.1088","article-title":"B cells in pancreatic cancer stroma","volume":"28","author":"Delvecchio","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172449","article-title":"Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens","volume":"8","author":"Yao","year":"2023","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1501943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:31:56Z","timestamp":1743147116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1501943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1501943"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1501943","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1501943"}}